Serum Metal Ion Levels in Modular Dual Mobility Hips

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-006924
    Sponsor Protocol Number: 16-006924

About this study

The purpose of this study is to determine if modular dual mobility (MDM) hips are at risk of increased serum metal ion levels.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:     

  • Any living patient with a history of modular dual mobility hip replacement.

Exclusion Criteria:    

  • Any patient who is a child or who we are not able to obtain follow-up information on.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Abdel, M.D.

Open for enrollment

Contact information:

Jennifer Krogman

(507)538-3562

Krogman.Jennifer@mayo.edu